EuropaBio and P-BIO launch the National Associations Council Summit 2021 - Building on Biotechnology: from vaccines to Economic Growth for Europe
The National Associations Council of EuropaBio is pleased to launch its 2021 Summit ‘Building on Biotechnology: From vaccines to economic Growth for Europe’ being hosted on May 10.
This inaugural Summit for the National Associations Council (NAC) will address how national priorities and synergies should be used to create an economic recovery pathway for Europe through biotechnology.
The Covid crisis has created many precedents for the faster delivery of biotechnologies to market, and Europe now has a significant opportunity to continue this momentum across all sectors and ensure a competitive global position. Initiatives such as the European Health Emergency Preparedness and Response Authority (HERA), plus the Industrial and Circular Economy Strategies are all enablers for biotechnology and will be addressed in the Summit.
The NAC Summit, jointly hosted with Portugal’s P-BIO in line with the current European Council Presidency, addresses its mission in two key sessions:
Innovation and delivery for vaccine across countries and value chains Large companies SMEs and universities active in vaccine development will present how they were able to bring the vaccines to patient in unprecedented speed. They will share the enabling factors behind their collaboration and development, including partnering, finance, policy and regulation.
Vaccine learning – Driving economic delivery with biotechnology SME presentations will demonstrate potential for the future, followed by a panel discussion with National Associations where priorities will be agreed for effective and impactful mobilisation of national resources to achieve a competitive Europe.
The Summit will develop and publish a position for EuropaBio’s National Associations and use this as a roadmap in the Council’s work in supporting European development through national actions and synergies.
Dr Claire Skentelbery, Director General of EuropaBio commented “Europe has a powerful engine to build competitiveness, through its Member and partner countries on the continent. This Summit reflects priorities and capabilities of countries of all sizes in Europe and helps to ensure that we all progress together”.
Filipa Sacadura, Secretary General of P-BIO added “Portugal’s biotech sector is actively involved in vaccine development within global partnerships and this Summit reflects our own national priorities to further build on the economic power of biotechnology in the future”.